My feeling is it will be the scope of the pivotal trial. 1000 patients vs say 400. I have no feel for it so waiting on numbers.
Also, if we can sell after the trial while we wait results. Where can we sell and for what price will be very interesting.
- Forums
- ASX - By Stock
- Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
AVR
anteris technologies global corp.
Add to My Watchlist
0.17%
!
$6.03

My feeling is it will be the scope of the pivotal trial. 1000...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.03 |
Change
0.010(0.17%) |
Mkt cap ! $93.45M |
Open | High | Low | Value | Volume |
$6.00 | $6.16 | $5.80 | $52.24K | 8.792K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 857 | $5.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.45 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 857 | 5.830 |
1 | 900 | 5.780 |
1 | 450 | 5.750 |
1 | 1000 | 5.610 |
2 | 3500 | 5.600 |
Price($) | Vol. | No. |
---|---|---|
6.450 | 1000 | 1 |
6.550 | 1092 | 1 |
6.650 | 100 | 1 |
6.910 | 1000 | 1 |
7.010 | 1000 | 1 |
Last trade - 15.36pm 20/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |